Upgrade to FINVIZ Elite to get real-time quotes, intraday charts, and advanced charting tools. Subscribe to Elite

NVO

Novo Nordisk ADR

Jan 16 • 04:00PM ET

62.33

+5.21 9.12 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: PVAL PPH AVDE PINK FTHI PID WCMI RVER AQEC OZEM

Scroll to Statements

Index	-	P/E	18.16	EPS (ttm)	3.43	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	5.99%
Market Cap	209.97B	Forward P/E	17.73	EPS next Y	3.52	Insider Trans	-	Shs Float	3.37B	Perf Month	27.31%
Enterprise Value	220.77B	PEG	3.32	EPS next Q	0.92	Inst Own	9.06%	Short Float	0.96%	Perf Quarter	11.12%
Income	15.29B	P/S	4.50	EPS this Y	15.86%	Inst Trans	-1.66%	Short Ratio	1.74	Perf Half Y	-3.08%
Sales	46.69B	P/B	10.36	EPS next Y	-4.04%	ROA	21.83%	Short Interest	32.38M	Perf YTD	22.50%
Book/sh	6.02	P/C	40.94	EPS next 5Y	5.34%	ROE	68.30%	52W High	93.80 -33.55%	Perf Year	-24.83%
Cash/sh	1.52	P/FCF	20.99	EPS past 3/5Y	25.78% 21.74%	ROIC	37.50%	52W Low	43.08 44.68%	Perf 3Y	-5.97%
Dividend Est.	1.77 (2.85%)	EV/EBITDA	9.58	Sales past 3/5Y	23.46% 18.15%	Gross Margin	81.93%	Volatility	3.01% 2.51%	Perf 5Y	77.02%
Dividend TTM	1.73 (2.77%)	EV/Sales	4.73	EPS Y/Y TTM	11.24%	Oper. Margin	42.41%	ATR (14)	2.04	Perf 10Y	127.65%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	0.57	Sales Y/Y TTM	18.71%	Profit Margin	32.76%	RSI (14)	73.30	Recom	2.24
Dividend Gr. 3/5Y	28.20% 21.81%	Current Ratio	0.78	EPS Q/Q	-21.84%	SMA20	14.55%	Beta	0.67	Target Price	60.96
Payout	35.93%	Debt/Eq	0.60	Sales Q/Q	11.80%	SMA50	23.13%	Rel Volume	2.30	Prev Close	57.12
Employees	76302	LT Debt/Eq	0.52	Earnings	Feb 04 BMO	SMA200	5.62%	Avg Volume	18.58M	Price	62.33
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.41% -3.47%	Trades		Volume	42,764,420	Change	9.12%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral

Show Previous Ratings

Jan-16-26 05:18PM	Stocks to Watch Friday Recap: J.B. Hunt, Salesforce, PNC (The Wall Street Journal) +9.12%
05:07PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:30PM	Stock Market Today: S&P 500, Dow Slide As Netflix, GE Aerospace Earnings Loom (Live Coverage) (Investor's Business Daily)
04:18PM	Todays Stock Movers: GE Vernova, Constellation Energy, Micron, AST SpaceMobile, Novo Nordisk, and More (Barrons.com)
04:12PM	Novo's Wegovy Pill Is Following In Zepbound's Footsteps And It's Only Been One Week (Investor's Business Daily)
02:54PM	Loading…
02:54PM	These Stocks Are Todays Movers: GE Vernova, Constellation Energy, Micron, AST SpaceMobile, Novo Nordisk, and More (Barrons.com)
01:43PM	Stocks to Watch Friday: J.B. Hunt, PNC, Verizon (The Wall Street Journal)
01:27PM	Stock Market Today: Dow, S&P Waffle As Battered Obesity Drug Giant Soars (Live Coverage) (Investor's Business Daily)
01:21PM	Novo Nordisk Jumps on Higher Wegovy Dose (GuruFocus.com)
01:06PM	Eli Lilly vs. Novo Nordisk: Which Is the Better Stock Buy? (Motley Fool)
12:59PM	Novo Nordisk Stock Jumps. The Wegovy Pill Is Back in Focus (GuruFocus.com)
12:46PM	Novo Nordisk (NVO) is "in a Battle," Says Jim Cramer (Insider Monkey)
12:07PM	Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data (Benzinga)
11:19AM	Novo Nordisk's Wegovy Weight Loss Pill Has a Strong Launch-and Other Reasons the Stock Is Rising (Barrons.com)
10:47AM	LLY Stock Falls After FDA Reportedly Delays Obesity Drug Ruling (Zacks)
10:22AM	Loading…
10:22AM	Novo shares jump on 'encouraging' Wegovy pill scripts data, analysts say (Reuters Videos)
09:33AM	Why A 'Solid' First Week For Oral Wegovy Bodes Well For Novo And Lilly (Investor's Business Daily)
09:26AM	Novo Nordisks Wegovy Weight Loss Shot Approved At Higher Dose in U.K. (The Wall Street Journal)
08:27AM	Micro shares surge on share buying by board member, and more stocks on the move (MarketWatch)
07:37AM	Novo Nordisk Stock Rises After U.K. Approves Higher Wegovy Dose for Weight Loss (Barrons.com)
06:58AM	Shares in Novo Nordisk spike sharply after U.K. regulator approves higher Wegovy dosage (MarketWatch)
06:48AM	UK Approves Higher Wegovy Dose for Obesity; Novo Nordisk Shares Rise 3% (GuruFocus.com)
Jan-15-26 04:40PM	Amgens Weight-Loss Drug Shows Promise With Less Frequent Dosing (Barrons.com)
03:10PM	Trump unveils his 'Great Healthcare Plan.' Analysts don't expect much of an impact. (MarketWatch)
02:59PM	Novo Nordisk Stock Dips As Company Faces GLP-1 Antitrust Lawsuit (Benzinga)
02:25PM	Eli Lilly Stock Slips After Antitrust Lawsuit Against GLP-1 Providers (Benzinga)
12:30PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:51AM	Half of GLP-1 users ditch their injections - and some are turning to other weight-loss methods instead (MarketWatch)
11:50AM	Novo Nordisk Foundation Commits Up to $860 Million to European Innovation Push (GuruFocus.com)
11:07AM	Structure Therapeutics CEO Says Compounding Threat Looms For Future Obesity Treatments (Benzinga)
10:17AM	Loading…
10:17AM	How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q4 Results? (Zacks)
09:35AM	Novo Nordisk stock target raised at UBS ahead of Wegovy Pill launch (Investing.com)
05:48AM	ASML Soars Above $500 Billion Value on TSMCs Upbeat Outlook (Bloomberg)
Jan-14-26 11:13PM	JPM26: Novo Nordisk reshapes its strategy under new CEO (Pharmaceutical Technology)
05:45PM	Novo Nordisk (NVO) Declines More Than Market: Some Information for Investors (Zacks)
02:46PM	Musk In The Rearview: Linda Yaccarino Puts X Behind Her To Become Tom Brady's Boss (Benzinga)
08:52AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
06:51AM	Lilly, chasing Novo, expects second-quarter FDA decision on obesity pill (BioPharma Dive)
02:37AM	Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs (Pharma Voice)
Jan-13-26 05:29PM	Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns (MarketBeat)
04:17PM	Novo CEO Sees Strong Demand for Wegovy Obesity Pill (Bloomberg)
03:00PM	Eli Lilly CFO: Weight-loss pill could have 20% global penetration (Yahoo Finance Video)
02:25PM	Novo Nordisk CEO warns of international competition headwinds, cites Lilly (Investing.com)
01:20PM	FDA Says No Clear Link Found Between Popular Weight Loss Drugs And Suicidal Thoughts, Review Ongoing (Benzinga)
12:53PM	Novo Nordisk Says 1.5 Million Americans Using Compounded GLP-1 Drugs (GuruFocus.com)
10:35AM	Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026? (Motley Fool)
09:58AM	Novo Nordisk Soars 19% in a Month: How Should You Play the Stock? (Zacks)
09:02AM	Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026? (Motley Fool)
06:53AM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:26AM	Novo Nordisk sees pills capturing over third of GLP-1 market by 2030 (Reuters Videos)
Jan-12-26 08:09PM	Novo Nordisk CEO: Wegovy not only reduces your weight, but it also shows cardiovascular benefits (CNBC TV)
08:09PM	Novo Nordisk CEO: People have been waiting for a GLP-1 pill (CNBC TV)
06:59PM	Expect a Busy Year in Obesity Drugs as New Pills Hit the Market (Barrons.com)
06:42PM	Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra (Reuters)
05:45PM	3 retail trends to watch in 2026, according to NRF 2026 (Yahoo Finance Video)
05:04PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:34AM	Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab (Yahoo Finance)
09:31AM	Fundsmith Equity Fund's Thoughts on Novo Nordisk (NVO) (Insider Monkey)
09:00AM	Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:43AM	An Investor's Guide to 2026 (Motley Fool)
Jan-11-26 11:03AM	This ETF Is Proof That the Healthcare Rebound Is Real (MarketBeat)
09:55AM	This Healthcare Stock Could Be One of the Best Companies to Own in 2026 (Motley Fool)
Jan-10-26 09:15AM	Amazon Pharmacy now offers Wegovy pill with insurance and cash options (TipRanks)
08:59AM	The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth (24/7 Wall St.)
Jan-09-26 07:47PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
06:52PM	Novo Nordisk and Eli Lilly can both gain GLP-1 market share this year, says Citi's Meacham (CNBC TV)
02:45PM	Novo Nordisk Is Getting a Major Boost from Amazon for Its New Wegovy Pill. Does That Make NVO Stock a Buy Here? (Barchart)
11:19AM	Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 (Reuters)
10:53AM	Rio Tinto, Glencore: Novo Nordisk: Stocks Overseas in Focus Friday (The Wall Street Journal)
10:34AM	Amazon Adds Novo Nordisk's Wegovy Pill to Pharmacy Platform (GuruFocus.com)
09:58AM	VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug (Zacks)
09:50AM	Amazon Pharmacy Begins Offering Wegovy Pill (The Wall Street Journal)
Jan-08-26 05:45PM	Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
01:47PM	Novo Nordisk quietly loses key Washington insider amid pricing war (TheStreet)
09:35AM	Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1? (Zacks)
09:15AM	3 of the Best Stocks Under $100 to Buy in 2026 (Motley Fool)
08:00AM	Biotech Stocks' Dark Winter Is Over. What That Means For Investors. (Investor's Business Daily)
05:22AM	Matt Damon Says He Hasn't Been 'That Light Since High School' Following Gluten-Free Diet, Intense Training For 'The Odyssey' (Benzinga)
Jan-07-26 11:25AM	Novo Nordisk Stock Climbs After Expanding Veeva Vault CRM Partnership (GuruFocus.com)
Jan-06-26 08:50PM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
06:31PM	Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill (CNBC TV)
06:20PM	Should Investors Be Concerned About This Pharmaceutical Giant's Latest Clinical Trial? (Motley Fool)
01:28PM	Eli Lilly, AI Drug-Discovery Company Nimbus Partner on Oral Obesity Treatment (The Wall Street Journal)
10:37AM	Daily Wegovy pill brings GLP-1 weight loss treatment to U.S. adults (TheStreet)
09:41AM	Can the US Launch of NVO's Wegovy Pill Reignite Momentum in 2026? (Zacks)
09:30AM	Should You Buy Eli Lilly Before It Reaches $1 Trillion in Market Value? (Motley Fool)
Jan-05-26 04:01PM	Novo releases GLP-1 pill, bitcoin price rises, Qualcomm's chips (Yahoo Finance Video) +5.19%
03:43PM	Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs (decrypt)
02:09PM	Novo Nordisk launches GLP-1 pill, bank stocks rally (Yahoo Finance Video)
01:07PM	Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan. (Investor's Business Daily)
12:28PM	Novo Nordisk Stock Rises as Wegovy Pill Hits the U.S. Market (GuruFocus.com)
11:54AM	Novo Nordisks Wegovy Pill Hits Pharmacies. Its the Latest Move in the Weight-Loss Showdown. (Barrons.com)
10:57AM	Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down. (MarketWatch)
10:37AM	LLY Up 28% in 3 Months: Is it the Right Time to Invest in the Stock? (Zacks)
09:57AM	Novo Nordisk Stock Rises on Launch of Weight-Loss Pills (The Wall Street Journal)
09:36AM	Stocks to Watch Monday: Chevron, Trump Media, AMD, Novo Nordisk (The Wall Street Journal)
09:20AM	Is It Time to Dump Your Shares of Eli Lilly? (Motley Fool)
08:42AM	Novo Nordisks Wegovy Pill Now Broadly Available Across U.S. (The Wall Street Journal)
08:34AM	Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026? (Zacks)
08:00AM	Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America (PR Newswire)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience